Cognizant and NVIDIA partner to apply generative AI for drug discovery with Nvidia's BioNeMo platform.
Cognizant and NVIDIA partner to apply generative AI for drug discovery, utilizing Nvidia's BioNeMo platform to improve productivity, speed, and success rates in pharmaceutical R&D. By leveraging AI technologies, researchers can rapidly analyze extensive datasets, accurately predict drug interactions, and create new, viable development pathways, ultimately accelerating the delivery of life-saving treatments.
March 19, 2024
8 Articles